https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Gefitinib treatment in hormone-resistant and hormone receptor-negative advanced breast cancer https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:7448 Sat 24 Mar 2018 08:38:51 AEDT ]]> Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:5531 Sat 24 Mar 2018 07:46:41 AEDT ]]>